ODONATE THERAPEUTICS INC's ticker is ODT and the CUSIP is 676079106. A total of 84 filers reported holding ODONATE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $7,252,000 | +10.3% | 377,700 | -22.8% | 0.15% | -7.8% |
| Q3 2020 | $6,573,000 | -64.5% | 489,432 | +11.9% | 0.17% | -67.1% |
| Q2 2020 | $18,512,000 | +55.9% | 437,231 | +1.7% | 0.51% | +3.5% |
| Q1 2020 | $11,872,000 | -14.9% | 430,000 | 0.0% | 0.49% | +11.3% |
| Q4 2019 | $13,954,000 | +24.7% | 430,000 | 0.0% | 0.44% | -1.1% |
| Q3 2019 | $11,193,000 | -29.1% | 430,000 | 0.0% | 0.45% | -21.9% |
| Q2 2019 | $15,777,000 | +60.4% | 430,000 | -3.4% | 0.57% | +50.7% |
| Q1 2019 | $9,839,000 | +57.0% | 445,000 | 0.0% | 0.38% | +28.0% |
| Q4 2018 | $6,266,000 | -25.9% | 445,000 | +2.2% | 0.30% | -3.3% |
| Q3 2018 | $8,453,000 | -3.7% | 435,500 | +9.5% | 0.31% | -9.5% |
| Q2 2018 | $8,782,000 | +8.1% | 397,750 | +3.7% | 0.34% | -2.6% |
| Q1 2018 | $8,123,000 | -20.8% | 383,500 | -6.5% | 0.35% | -25.4% |
| Q4 2017 | $10,250,000 | – | 410,000 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 4,207,086 | $5,553,000 | 0.28% |
| Samsara BioCapital, LLC | 700,421 | $925,000 | 0.23% |
| Hennion & Walsh Asset Management, Inc. | 69,264 | $91,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 384,995 | $506,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 43,752 | $58,000 | 0.00% |
| SIMPLEX TRADING, LLC | 2,000 | $2,000 | 0.00% |
| Newbridge Financial Services Group, Inc. | 47 | $0 | 0.00% |
| BESSEMER GROUP INC | 230 | $0 | 0.00% |